Skip to main content

LETYBO (CROMA Australia Pty Ltd)

Product name
LETYBO
Date registered
Evaluation commenced
Decision date
Approval time
222 (255 working days)
Active ingredients
letibotulinumtoxinA
Registration type
NCE/NBE
Indication

LETYBO is indicated for the temporary improvement in the appearance of moderate to severe glabellar frown lines in adults.

Help us improve the Therapeutic Goods Administration site